Views - Page 2 - Lumanity

Opportunities for Enhanced Communication between Manufacturers and US Payers (Part 1)

In the first in a three-part series, our Value Strategy and Services team in the United States provide an introduction to Pre-Approval Information Exchange and communicating Health Care Economic Information to payer audiences, including exploring current US Food and Drug Administration (FDA) guidance on payer communications.

View Jan 9, 2023

Choosing the Best Value Communication Strategy for Your Current Challenges

View Dec 15, 2022

Serving the Underserved: Helping Marginalized Communities Develop Sustainable Programs for Life

View Dec 9, 2022

Respiratory Disease and RNA Therapy: A breath of fresh air

View Nov 29, 2022

Data saves lives: how do we build belief and trust in data in patient communities?

View Nov 29, 2022

The Key Questions to Ask to Optimize Early HEOR Strategy

We present to you nine key questions to help with planning your evidence generation strategy before your pivotal trial to ensure you have a strong evidence base for your product at time of reimbursement.

View Nov 17, 2022

‘Shining’ a Light on Young Adults with Cancer

View Oct 27, 2022

Is it Possible to Democratize Scientific Knowledge Without Addressing Scientific Literacy?

View Oct 26, 2022

Is the whole greater than the sum of its parts?

View Oct 18, 2022

Metastatic Breast Cancer Awareness Day is Here

View Oct 13, 2022

Living Well with Rheumatoid Arthritis: Engaging Patients Highlights the Unmet Need

We sat down with Graeme Johnston, rheumatoid arthritis (RA) patient advocate and Board Member, Patient Focused Medicines Development (PFMD) to talk about his active role in the RA community and his experiences working with pharma companies to advocate for patients with RA during the 15 years he has been living with the condition.

View Sep 27, 2022